LivaNova (LIVN) Total Non-Current Liabilities (2015 - 2026)
LivaNova's (LIVN) quarterly Total Non-Current Liabilities came in at $1.2 billion in Q2 2026, down 12.66% year-over-year from $1.3 billion in Q2 2025, and down 3.3% quarter-over-quarter from $1.2 billion in Q1 2026.
Analysis
LivaNova (LIVN) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
LivaNova has disclosed Total Non-Current Liabilities across 12 years of filings, most recently posting $1.2 billion for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 12.66% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.2 billion (down 12.66% YoY), while the FY2025 annual figure was $1.3 billion, up 19.25% from the prior year.
- Total Non-Current Liabilities came in at $1.2 billion for Q2 2026 at LivaNova, down from $1.2 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.4 billion in Q1 2025 to a low of $920.2 million in Q2 2022.
- Average Total Non-Current Liabilities over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2024.
- Year-over-year, Total Non-Current Liabilities retreated 26.91% in 2022 and increased 27.02% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $995.6 million in 2022, then climbed by 7.58% to $1.1 billion in 2023, then gained by 2.88% to $1.1 billion in 2024, then advanced by 19.25% to $1.3 billion in 2025, then declined by 11.52% to $1.2 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $1.2 billion in Q2 2026, $1.2 billion in Q1 2026, and $1.3 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.44 Bn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 1.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Bn |
| Mar 31, 2026 | 1.20 Bn |
| Dec 31, 2025 | 1.31 Bn |
| Sep 30, 2025 | 1.34 Bn |
| Jun 30, 2025 | 1.33 Bn |
| Mar 31, 2025 | 1.44 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.11 Bn |
| Mar 31, 2024 | 1.13 Bn |
| Dec 31, 2023 | 1.07 Bn |
| Sep 30, 2023 | 1.01 Bn |
| Jun 30, 2023 | 1.01 Bn |
| Mar 31, 2023 | 977.43 Mn |
| Dec 31, 2022 | 995.59 Mn |
| Sep 30, 2022 | 982.77 Mn |
| Jun 30, 2022 | 920.15 Mn |
| Mar 31, 2022 | 954.37 Mn |
| Dec 31, 2021 | 819.48 Mn |
| Sep 30, 2021 | 786.83 Mn |